Pathophysiology and Treatment of Atherosclerotic Disease in Peripheral Arteries

Erscheinungsjahr 2024
ISBN: 978-0-443-13593-4
Verlag: Elsevier Science

Buch, Englisch, 252 Seiten, Format (B × H): 191 mm x 235 mm, Gewicht: 530 g

Pathophysiology and Treatment of Atherosclerotic Disease in Peripheral Arteries is a thorough review of the disease written by experts studying its detection and treatment. These state-of-the-art chapters summarize emerging knowledge about this important area of medicine. The pathophysiology and treatment of peripheral artery (PAD) disease remains poorly understood even by practitioners. Often it is assumed that PAD should be treated in a similar fashion to coronary artery disease (CAD), when in fact recent data suggest a distinct pathophysiology with genetic risk having some but not complete overlap with CAD.

This is a novel reference of emerging data on the factors behind its development and progression, detection, and treatment suggest an emerging paradigm for this disease.

Autoren/Hrsg.

Finn, Aloke Virmani

Fachgebiete

• Mathematik | Informatik EDV | Informatik Business Application Unternehmenssoftware
• Wirtschaftswissenschaften Betriebswirtschaft Unternehmensforschung

Inhaltsverzeichnis

1. Introduction
2. Atherosclerosis- pathology of lower extremity atherosclerosis
3. Epidemiology of PAD
4. Molecular Understanding of Peripheral Arterial Disease

5. Non-invasive imaging of CT and MRA in Evaluation of PAD

6. Medical Therapy of PAD: Joshua Beckman
7. Intravascular Imaging: Role in PAD

8. Interventional Treatment of PAD: Atherectomy

9. Interventional Treatment of PAD: Drug Coated Balloons and Stents
10. Future Directions

Über Autor(innen)

Finn, Aloke Virmani
Dr. Aloke Virmani Finn is a physician-scientist whose focus is on the pathology of cardiovascular disease and its treatment.?He serves as the Medical Director and Chief Scientific Officer for CVPath Institute where he oversees device development research and runs a molecular lab with focus on the molecular understanding of vascular wall injury and healing, genetics of sudden cardiac death and molecular basis of coronary artery disease.? When not running CVPath, he performs interventional cardiology procedures at University of Maryland.